Lung 18F-Fluorodeoxyglucose Positron Emission Tomography for Diagnosis and Monitoring of Pulmonary Arterial Hypertension
Glenn Marsboom(Johnson & Johnson (United States)), Stephen L. Archer(Queen's University), Erik Morrow(University of Alberta), Péter T. Tóth(University of Chicago), Chad R. Haney(Northwestern University), Thenappan Thenappan(University of Minnesota), Lin Piao(University of Alberta), John Ryan(Northwestern University), Peter Bache-Wiig(University of Wisconsin–Madison), Jonathan Paul(University of Chicago), Chin-Tu Chen(University of Chicago), Christian Wietholt(University of Chicago)
American Journal of Respiratory and Critical Care Medicine
January 13, 2012
Cited by 179
Related Papers
Pediatric Pulmonary Hypertension
|Circulation|2015|1.1k
Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer
|The FASEB Journal|2012|606
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
|Nature Medicine|2021|599
Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension
|Circulation|2002|578
Basic Science of Pulmonary Arterial Hypertension for Clinicians
|Circulation|2010|488